Keyphrases
Major Depressive Disorder
76%
Electroconvulsive Therapy
61%
Testosterone
56%
Transcranial Magnetic Stimulation
52%
Antidepressants
51%
Repetitive Transcranial Magnetic Stimulation (rTMS)
50%
Schizophrenia
50%
Hamilton Depression Rating Scale (HAM-D)
42%
Obsessive-compulsive Disorder
35%
Placebo
30%
Serotonergic Drugs
28%
Randomized Placebo-controlled Trial
25%
Depressive Symptoms
25%
Schizophrenic Patients
24%
Testosterone Gel
23%
Dorsolateral Prefrontal Cortex (DLPFC)
23%
Anorexia Nervosa
23%
Perceptual Filling-in
23%
Implantable Defibrillator
23%
Panic Disorder
23%
Self-stigma
23%
HF-rTMS
23%
Placebo-controlled
23%
Motor Threshold
22%
Testosterone Replacement Therapy
18%
Remission
18%
Psychiatric Symptoms
18%
Randomized Double-blind
17%
Dysthymia
17%
Novel Treatments
16%
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
16%
Flanker
16%
Cigarette Craving
15%
Treatment Response
15%
Serotonergic
14%
Randomized Controlled Trial
14%
Antidepressant Treatment
13%
Comorbid Depression
13%
Mental Health Stigma
13%
Anxiety Symptoms
13%
DSM-IV Diagnoses
13%
Comorbid
13%
Healthy Volunteers
13%
Prefrontal Cortex
13%
Healthy Controls
12%
Primary Prevention
11%
Retrospective Case Series
11%
Computer-based Assessment
11%
Assisted Therapy
11%
Stimulation Treatment
11%
Neuroscience
Transcranial Magnetic Stimulation
100%
Antidepressant
76%
Major Depressive Disorder
73%
Placebo
72%
Electroconvulsive Therapy
51%
Dementia Praecox
49%
Depression
36%
Hamilton Rating Scale for Depression
32%
Serotonergic
29%
Dorsolateral Prefrontal Cortex
28%
Obsessive-Compulsive Disorder
23%
Panic Disorder
23%
Dysthymia
23%
Serotonin
14%
Hypogonadism
14%
Treatment of Depression
13%
Hallucination
13%
Cognitive Disorders
13%
Motor Evoked Potential
13%
Anxiety Disorder
11%
Transcranial Direct Current Stimulation
11%
Naltrexone
11%
Remifentanil
11%
Visual Pathway
11%
Spectrum Disorder
11%
Parkinson's Disease
11%
Ketamine
11%
Varenicline
11%
Crossover Study
11%
Cannabis
11%
Bipolar Disorder
11%
Mood Disorder
11%
Ropinirole
11%
Quetiapine
11%
Anorexia Nervosa
11%
Mini-International Neuropsychiatric Interview
11%
Randomized Controlled Trial
11%
MDMA
11%
Posttraumatic Stress Disorder
11%
Propofol
11%
Functional Connectivity
11%
Prefrontal Cortex
11%
Selective Serotonin Reuptake Inhibitor
7%
Amygdala
6%
Eating Disorder
6%
Personality Disorder
5%
Psychiatric Assessment
5%
Social Anxiety Disorder
5%
Agoraphobia
5%
Agonist
5%
Medicine and Dentistry
Symptom
48%
Electroconvulsive Therapy
47%
Placebo
47%
Transcranial Magnetic Stimulation
28%
Obsessive Compulsive Disorder
23%
Implantable Automatic Defibrillator
23%
Controlled Clinical Trial
23%
Depression
17%
Yale-Brown Obsessive Compulsive Scale
16%
Antidepressant
15%
Drug Therapy
15%
Androgen Therapy
14%
Dysthymia
13%
Epileptic Seizure
13%
Clinical Global Impression
13%
Treatment Response
12%
Prefrontal Cortex
12%
International Index of Erectile Function
11%
Systematic Review
11%
Therapy Effect
11%
Propofol
11%
Supplementation
11%
Meta-Analysis
11%
Prospective Study
11%
Retrospective Study
11%
Patient-Data
11%
Cannabis Use
11%
Promethazine
11%
Anorexia Nervosa
11%
Cardiovascular System
11%
Remifentanil
11%
Parkinson's Disease
11%
Vision
11%
Seizure Threshold
11%
Primary Prevention
11%
Visual Pathway
11%
Naltrexone
11%
Panic Disorder
11%
Middle Age
11%
Posttraumatic Stress Disorder
11%
Transcranial Direct Current Stimulation
11%
Midomafetamine
11%
Hamilton Rating Scale for Depression
11%
Major Depressive Episode
10%
Unified Parkinson's Disease Rating Scale
9%
Effect Size
8%
Outpatient
8%
Montgomery-Åsberg Depression Rating Scale
7%
Eating Disorder
6%
Shock (Circulatory)
5%
